Probiotics for Mental Health: The Gut-Brain Connection, Best Strains & What the Science Shows
A hub guide to psychobiotics, the microbiome-gut-brain axis, and clinically researched strains for anxiety, mood, and beyond
The idea that bacteria in your gut could influence how you feel sounds like the premise of a science-fiction story. Yet a rapidly expanding body of peer-reviewed research has placed the relationship between gut microbiota and mental health at the forefront of neuroscience. The gut is now widely recognized as a second brain—one that produces neurotransmitters, signals the central nervous system through the vagus nerve, and shapes the hormonal environment that governs stress responses.
The good news for anyone exploring natural approaches to mental wellbeing: specific probiotic strains have been studied in randomized controlled trials and meta-analyses for their effects on anxiety, low mood, stress reactivity, and cognitive function. This article is your science-grounded starting point—a hub covering the mechanisms behind probiotics and mental health, the strains with the strongest clinical evidence, and what realistic expectations look like based on the current data.
One clarification before we begin: this article is an educational overview, not medical advice. If you are experiencing symptoms of a psychiatric condition, please work with a qualified healthcare professional. Probiotics are best understood as a supportive strategy—not a replacement for clinical care.
Key Takeaways
- The gut produces approximately 95% of the body's serotonin, most of which resides in the gut itself and communicates with the brain via the vagus nerve and enteroendocrine signaling.[1]
- A 2025 meta-analysis of 23 RCTs found probiotics produced a significant reduction in depression symptoms (SMD: −0.96) and a moderate reduction in anxiety symptoms (SMD: −0.59) in clinically diagnosed populations.[2]
- Lactobacillus rhamnosus directly modulates GABA receptor expression in the brain via the vagus nerve, reducing stress-induced corticosterone and anxiety-related behavior in research models.[3]
- Bifidobacterium longum reduced perceived psychological stress and improved sleep quality in a randomized, double-blind, placebo-controlled trial of healthy adults with mild-to-moderate stress.[4]
- Lactobacillus plantarum reduced anxiety and stress symptoms as early as 8 weeks in a randomized controlled trial of stressed adults, accompanied by reduced cortisol and pro-inflammatory cytokines.[5]
- Multi-strain formulas containing both Lactobacillus and Bifidobacterium species were associated with significant decreases in depressive symptoms in a 2024 strain-specific meta-analysis across 12 RCTs.[6]
- A 2024 systematic review of 51 psychobiotic trials (3,353 patients) found notably high effectiveness specifically in treating depression symptoms, with treatments commonly using Lactobacillus and Bifidobacteria strains over 4–24 weeks.[7]
The Gut-Brain Axis: Why Your Gut Is Your Second Brain
The term "gut-brain axis" refers to the bidirectional communication network linking the gastrointestinal tract to the central nervous system. This axis operates through neural, hormonal, immune, and metabolic pathways—and the gut microbiome sits at its center as both participant and regulator.
The most direct pathway is the vagus nerve, a superhighway of information that runs from the brainstem to the abdomen. Roughly 80–90% of the signals traveling this nerve move upward—from gut to brain—meaning your microbiome is constantly transmitting information that shapes your emotional state, stress responses, and cognitive function. A deep-dive on the neuroscience behind this system is available in our article on the gut-brain axis and mental wellbeing.
Beyond the vagus nerve, the gut communicates with the brain through three additional channels:
The neuroendocrine system. Enterochromaffin cells lining the gut produce approximately 95% of the body's total serotonin—the very neurotransmitter that antidepressants are designed to modulate.[1] The composition of your gut microbiome directly influences how much serotonin is synthesized and how it signals upstream to the brain.
The immune system. About 70% of the immune system resides in the gut. Gut bacteria regulate the production of cytokines—chemical messengers that drive inflammation. Elevated inflammatory cytokines are a consistent finding in people with depression and anxiety, and dysbiosis (an imbalanced microbiome) can contribute to the chronic low-grade inflammation that underpins many mood disorders.[8]
Microbial metabolites. Gut bacteria produce short-chain fatty acids (SCFAs) like butyrate and propionate, which cross the blood-brain barrier and regulate microglial homeostasis—the brain's immune cells—influencing mood, memory, and neurological health. The gut also produces GABA, the primary inhibitory neurotransmitter in the central nervous system, through bacterial fermentation.[9]

The "Second Brain" Is Not a Metaphor
The enteric nervous system—the network of neurons lining the gastrointestinal tract—contains more nerve cells than the spinal cord. It develops from the same embryonic tissue as the brain and operates semi-autonomously. When researchers describe the gut as a "second brain," they are speaking with anatomical precision. Understanding this helps explain why supporting the gut microbiome has measurable downstream effects on emotional regulation, stress tolerance, and cognitive clarity.
When gut microbiota becomes disrupted through poor diet, antibiotics, chronic stress, or other factors, this bidirectional communication breaks down. Research has documented that gut dysbiosis—an imbalance favoring pathogenic over beneficial bacteria—is associated with reduced microbial diversity and fewer SCFA-producing bacteria in people experiencing anxiety, while probiotic interventions show promise in restoring balance.[8]
Four Ways Probiotics Influence Mental Health
Probiotic bacteria interact with the gut-brain axis through several overlapping mechanisms. Understanding these pathways helps clarify why certain strains outperform others—and why a diverse, multi-strain formula tends to offer broader support than a single-strain product.
🧠 Neurotransmitter Production
Specific Lactobacillus and Bifidobacterium species produce GABA, the brain's primary calming neurotransmitter, and support serotonin synthesis by increasing tryptophan availability. L. rhamnosus has been shown to directly alter GABA receptor expression in the brain via vagal signaling.[3]
🔥 Inflammation Modulation
Probiotics reduce pro-inflammatory cytokines like interferon-γ and TNF-α while increasing anti-inflammatory IL-10. This matters because neuroinflammation is increasingly recognized as a key driver of depression and anxiety.[5]
⚡ HPA Axis Regulation
The hypothalamic-pituitary-adrenal (HPA) axis governs the stress hormone cascade. Dysbiosis can chronically activate this system, elevating cortisol. Certain probiotic strains reduce stress-induced corticosterone elevation and normalize HPA axis reactivity.[3]
🛡️ Gut Barrier Integrity
A compromised gut lining allows bacterial endotoxins (LPS) to enter the bloodstream, triggering systemic inflammation that reaches the brain. Probiotics strengthen tight junctions and support intestinal barrier repair, reducing this endotoxin translocation.[8]

These mechanisms do not operate in isolation. A well-formulated multi-strain probiotic can engage all four pathways simultaneously—which is one reason why research comparing multi-strain to single-strain formulas in the mental health context shows both approaches can be effective, with multi-strain formulas offering more comprehensive system-wide support.[2]
It's also worth noting the role that gut microbiota plays in tryptophan metabolism. Tryptophan is the dietary precursor to serotonin. Beneficial gut bacteria help direct tryptophan down the serotonergic pathway (toward serotonin production) rather than the kynurenine pathway, which is associated with neuroinflammatory compounds. This metabolic competition partially explains why supporting microbial diversity may support mood regulation independent of direct neurotransmitter production.[9]
Best Probiotic Strains for Mental Health: What the Research Shows
Not every probiotic strain has been studied for mental health outcomes. What follows focuses exclusively on strains with published clinical or mechanistic evidence relevant to mood, anxiety, and stress—and specifically strains included in MicroBiome Restore's 26-strain formula.
Lactobacillus rhamnosus: The GABA Connection
L. rhamnosus is among the most extensively studied probiotic strains in the context of the gut-brain axis. In a landmark study published in PNAS, mice administered L. rhamnosus (JB-1) showed region-dependent alterations in GABA receptor expression throughout the brain, including the prefrontal cortex, hippocampus, and amygdala—areas directly involved in anxiety and emotional regulation. The same mice showed significantly reduced stress-induced corticosterone levels and less anxiety- and depression-related behavior. Critically, when the vagus nerve was severed, all behavioral and neurochemical changes disappeared—confirming the vagal pathway as the mechanism of communication.[3]
These findings have driven substantial follow-up research into L. rhamnosus's broader health benefits and its role as a candidate psychobiotic strain. It is one of the most mechanistically well-characterized bacteria in microbiome-mental health research.
Lactobacillus plantarum: Stress, Anxiety, and Cortisol
L. plantarum has accumulated a compelling body of human clinical trial data for stress and anxiety outcomes. In a randomized, double-blind, placebo-controlled trial of 111 stressed adults, supplementation with L. plantarum DR7 for 12 weeks reduced anxiety symptoms (p = 0.001), stress (p = 0.024), and total psychological scores (p = 0.022) as early as 8 weeks compared to placebo. Plasma cortisol was reduced, accompanied by decreases in pro-inflammatory cytokines IFN-γ and TNF-α and increases in anti-inflammatory IL-10.[5]
A separate 12-week RCT of 103 stressed adults testing L. plantarum P8 found significant reductions in stress (p = 0.048), anxiety (p = 0.031), and total psychological scores (p = 0.041) after just 4 weeks, alongside enhancements in memory and cognitive performance.[10] The broader clinical evidence for L. plantarum's health benefits extends well beyond mental health—but the anxiety and stress data are among its most consistent findings across human trials.
Bifidobacterium longum subsp. longum: Stress and Sleep
B. longum subsp. longum is particularly well-documented for its effects on psychological stress. In a 2023 randomized, double-blind, placebo-controlled exploratory clinical trial of 45 healthy adults with mild-to-moderate stress, six weeks of supplementation with B. longum NCC3001 significantly reduced perceived stress and improved subjective sleep quality compared to placebo. Momentary wellbeing assessments confirmed the benefit, making this one of the few probiotic trials to document effects on daily subjective experience rather than questionnaire scores alone.[4]
A separate pilot study published in Gastroenterology found that B. longum NCC3001 reduced depression scores and altered activity in brain regions associated with negative emotional processing—including the amygdala—in patients with IBS, with the changes in brain activation correlating with improvements in depression scores. This functional MRI evidence provides a direct neurological link between this strain and emotional processing.[11]
Bifidobacterium breve: Tryptophan, Serotonin, and Major Depression
B. breve CCFM1025 was evaluated in a randomized clinical trial specifically in patients with Major Depressive Disorder (MDD). The intervention produced significant improvements in depression scores while positively influencing gut microbiome composition and tryptophan metabolism—the metabolic pathway that controls how much of the dietary precursor to serotonin reaches serotonin-producing cells. The authors identified tryptophan/serotonin pathway modulation as the primary mechanism of antidepressant action.[12]
Lactobacillus acidophilus, L. casei, B. bifidum, and B. lactis: Convergent Evidence
A 2024 strain-specific meta-analysis pooling 12 RCTs and 707 participants identified a cluster of strains—including L. acidophilus, L. paracasei, L. casei, L. plantarum, L. salivarius, B. bifidum, B. lactis, B. breve, and B. longum—as collectively demonstrating a significant decrease in depressive symptoms (MD: −2.69; 95% CI: −4.22 to −1.16) using the Beck Depression Inventory.[6] All of these strains are present in MicroBiome Restore's formula.
The evidence for L. acidophilus specifically includes its role in vaginal and immune health alongside gut health—underscoring how systemic health and mental health are intertwined through the microbiome. B. bifidum and B. lactis both support intestinal barrier integrity and modulate immune cytokine profiles in ways that reduce neuroinflammatory signaling.

| Strain | Primary Mental Health Evidence | Key Mechanism |
|---|---|---|
| L. rhamnosus | Reduced anxiety & corticosterone; GABA receptor modulation | Vagus nerve / GABAergic signaling[3] |
| L. plantarum | Reduced stress, anxiety, cortisol in RCTs (human) | Cytokine modulation / serotonin-dopamine pathways[5] |
| B. longum subsp. longum | Reduced perceived stress; improved sleep quality (RCT) | HPA axis regulation / limbic activity[4] |
| B. breve | Improved MDD symptoms via tryptophan metabolism (RCT) | Tryptophan / serotonin pathway[12] |
| L. acidophilus, L. casei, B. bifidum, B. lactis, B. longum | Significant reduction in BDI depression scores (meta-analysis) | Multi-pathway / neurotransmitter support[6] |
26 Strains. All the Ones That Matter for Mental Health.
MicroBiome Restore is a 26-strain, 15 billion CFU synbiotic probiotic with no fillers—no microcrystalline cellulose, no magnesium stearate, no titanium dioxide. Every strain above is included, alongside organic whole-food prebiotics to fuel their colonization.
What the Research Actually Shows: Honest Context
The evidence for probiotics and mental health is genuinely encouraging—but a clear-eyed review requires acknowledging what the research does and does not yet establish.

What the Evidence Supports
The most rigorous recent evidence comes from a comprehensive 2025 systematic review and meta-analysis published in Nutrition Reviews, encompassing 23 randomized controlled trials involving 1,401 clinically diagnosed patients. The results were statistically significant: probiotics demonstrated a substantial reduction in depression symptoms (SMD: −0.96; 95% CI: −1.31, −0.61) and a moderate reduction in anxiety symptoms (SMD: −0.59; 95% CI: −0.98, −0.19). Notably, 8 weeks of probiotic use was sufficient to produce significant improvements in both depressive and anxiety symptoms in clinical populations.[2]
A separate 2024 systematic review of 51 psychobiotic clinical trials spanning 3,353 patients identified high effectiveness for depression symptoms specifically, with Lactobacillus and Bifidobacteria strains used over 4–24 week periods as the most studied and consistently effective interventions.[7]
The 2024 strain-specific meta-analysis further found that combining Lactobacillus and Bifidobacterium species—the formulation approach used by multi-strain synbiotics—produced results comparable to single-strain interventions while covering a broader range of symptom profiles and mechanistic pathways.[6]
What Requires More Research
It is important to note that high heterogeneity exists across studies—differences in strain selection, dosage, trial duration, and patient population make direct comparisons difficult. Most trials to date use probiotics as an adjunct to standard care rather than as standalone treatments. The Nutrition Reviews meta-analysis specifically highlighted a need for larger trials examining remission rates and optimal dosage trajectories.[2]
Probiotics are also not universally interchangeable for mental health benefits. Strain specificity matters—results with one strain should not be extrapolated to all probiotics. This is one reason the scientific literature increasingly distinguishes the concept of "psychobiotics" (probiotic strains with demonstrated mental health effects) from probiotics in general.
An Important Note on Mental Health and Supplement Use
Probiotics are a supportive nutritional strategy backed by emerging science—not a clinical treatment for depression, anxiety disorder, or other psychiatric conditions. If you are experiencing significant mental health symptoms, please work with a healthcare provider. Probiotic use can complement but should never replace evidence-based mental health care.
For context on related research areas covered on this blog, our articles on probiotics for anxiety and probiotics and sleep provide deeper coverage of the specific clinical trials in those subdomains.
Choosing a Probiotic for Mental Health Support
If the gut-brain axis research has you thinking about probiotic supplementation for mental wellbeing, strain selection and formulation quality are the two most important variables.
Strain Diversity
The mental health benefits documented in clinical research span both Lactobacillus and Bifidobacterium genera. No single strain covers all four mechanisms discussed above—GABA production, serotonin support, cytokine modulation, and gut barrier integrity each tends to be driven by different species. A multi-strain formula that includes both genera provides the broadest mechanistic coverage and more closely mirrors the complexity of a healthy human microbiome.
Our guide to single-strain vs. multi-strain probiotics explores the tradeoffs in depth, but for mental health applications, the convergent evidence points toward multi-strain formulas.
Clean Formulation: Why Fillers Undermine Your Investment
Many commercial probiotics contain inactive ingredients that can work against the very gut environment you're trying to support. Microcrystalline cellulose (MCC) is the most common filler in probiotic supplements—a material with emerging concerns for gut microbiome disruption that is included for manufacturing convenience, not health benefit. Magnesium stearate, a flow agent used in most capsule manufacturing, has been shown to form biofilms that impair the absorption of both nutrients and probiotic organisms.
For anyone supplementing with mental health support as a goal, these formulation details are not trivial. A probiotic in an MCC-laden capsule delivers both the potential benefits of the strains and a concurrent hit of a substance that may interfere with mucosal function. Learning to read probiotic supplement labels for these hidden fillers is worth the few minutes it takes.

Prebiotic Support
Probiotic strains need fuel to survive, colonize, and remain metabolically active in the gut. Prebiotics—fermentable fibers that selectively feed beneficial bacteria—are what determines whether ingested probiotics persist long enough to exert their effects on the gut-brain axis. MicroBiome Restore includes seven certified organic whole-food prebiotics, including inulin-rich Jerusalem artichoke, acacia fiber, and maitake mushroom—all of which preferentially support Lactobacillus and Bifidobacterium populations. This is the distinction between a probiotic and a synbiotic: the combination of probiotic strains with prebiotics specifically chosen to support their growth.
CFU Count in Context
Colony-forming units (CFU) quantify viable organisms per serving. Clinical trials demonstrating mental health benefits have generally used doses in the range of 1–10 billion CFU per strain. A 15 billion CFU multi-strain formula—the dose in MicroBiome Restore—provides therapeutic-range delivery across 26 bacterial species. Higher CFU counts beyond this range do not consistently produce stronger outcomes; strain diversity and formulation quality tend to matter more than raw CFU numbers.
What Makes MicroBiome Restore Different
MicroBiome Restore was formulated around a single principle: no fillers, no compromises. The capsule itself is pullulan—a fermented, prebiotic material that provides delayed release without the synthetic coatings used in most supplements. Every ingredient is either a clinically relevant probiotic strain or an organic whole-food prebiotic. There is no microcrystalline cellulose, no magnesium stearate, and no titanium dioxide. For a complete breakdown, see our complete MicroBiome Restore guide.
How Long Do Probiotics Take to Work for Mental Health?

Timeline is one of the most important practical questions—and the clinical research offers reasonably consistent guidance. In the 2025 meta-analysis, up to 8 weeks of supplementation was identified as sufficient to produce significant effects on depression and anxiety symptoms in clinically diagnosed populations.[2] Individual RCTs have documented measurable improvements in stress and anxiety scores as early as 4–8 weeks when using targeted Lactobacillus strains.[5][10]
For gut ecosystem changes—the microbiome shifts that underpin the gut-brain axis benefits—a longer window of 12+ weeks is often cited as the timeframe for durable colonization shifts to occur. Our detailed guide on how long probiotics take to work covers the clinical timeline evidence across different health outcomes.
Consistency matters more than any other variable. A probiotic taken intermittently does not produce the persistent microbiome changes needed to influence the gut-brain axis in a sustained way. Daily supplementation, alongside dietary habits that feed beneficial bacteria, is the approach most consistent with how clinical trials producing positive mental health outcomes were structured.
Frequently Asked Questions
What is a psychobiotic?
A psychobiotic is a probiotic strain that produces a demonstrable benefit to mental health through action on the gut-brain axis. The term was coined to distinguish probiotics with documented neurological or psychiatric effects from those studied only for gastrointestinal outcomes. Strains like L. rhamnosus, L. plantarum, and B. longum subsp. longum are among the most studied psychobiotics based on human clinical trial data.
Can probiotics replace antidepressants or anti-anxiety medication?
The current evidence does not support using probiotics as a replacement for prescribed psychiatric medication. The research has predominantly evaluated probiotics as adjunctive therapies—supplements taken alongside standard care. If you are currently taking psychiatric medication, do not make changes without consulting your prescribing physician. Probiotics are best understood as a supportive nutritional strategy rather than a clinical intervention.
Which probiotic strains are best for anxiety specifically?
The strains with the strongest human clinical evidence for anxiety include L. rhamnosus (vagal GABA modulation), L. plantarum (cortisol and cytokine reduction), and B. longum subsp. longum (stress reduction and sleep improvement). The 2025 meta-analysis found that probiotics produced a moderate, statistically significant reduction in anxiety symptoms (SMD: −0.59) across 9 trials in clinically diagnosed populations.[2] Our dedicated article on probiotics for anxiety covers these strains and their mechanisms in more depth.
Do probiotics help with sleep and mood?
Yes—both sleep and mood are documented outcomes in probiotic clinical trials. B. longum subsp. longum specifically improved subjective sleep quality scores alongside stress reduction in a 2023 RCT.[4] Bifidobacterium longum 1714 has also been studied for sleep quality improvement in a separate double-blind RCT. The gut-brain axis mechanisms that influence mood—neurotransmitter synthesis, HPA axis modulation, inflammation reduction—overlap substantially with those that govern sleep quality. Our article on probiotics for sleep covers the dedicated sleep research in detail.
How does gut health relate to mental health?
The relationship operates through the gut-brain axis—the bidirectional communication network between the GI tract and the central nervous system. The gut produces approximately 95% of the body's serotonin, houses about 70% of the immune system, and communicates with the brain directly via the vagus nerve. Disruptions to gut microbial balance (dysbiosis) have been consistently associated with increased neuroinflammation, altered neurotransmitter availability, and dysregulated stress responses—all of which are implicated in mood disorders. Our article on the gut-brain axis and mental wellbeing explores this connection in depth.
Is a 15 billion CFU probiotic enough for mental health benefits?
Clinical trials demonstrating significant mental health benefits have used individual strain doses ranging from 1 to 10 billion CFU. A 15 billion CFU multi-strain formula distributes meaningful therapeutic amounts across numerous species simultaneously. Based on the published evidence, 15 billion CFU across a well-chosen multi-strain formula is well within the range used in successful RCTs. Higher counts are not consistently associated with greater benefit—strain selection and formulation quality remain more important variables.
The Bottom Line: Your Gut Health and Your Mental Health Are One System
The evidence connecting gut microbiota to mental health is no longer peripheral—it is mechanistically grounded, supported by multiple meta-analyses, and actively shaping both research agendas and clinical thinking about mood disorders. The gut-brain axis is a real and well-characterized biological system. The probiotic strains that influence it are identifiable. And the timeline and formulation considerations for meaningful supplementation are documented in peer-reviewed literature.
What this means practically: if you are interested in supporting mental wellbeing through gut health, you now have a research-based framework for evaluating products. Look for multi-strain formulas spanning both Lactobacillus and Bifidobacterium genera, containing strains with documented psychobiotic evidence, delivered in a filler-free formulation with prebiotic support—and give the intervention at least 8–12 consistent weeks to produce measurable effects.
For continued reading, explore our related hub articles: the gut-brain axis and mental wellbeing, probiotics for anxiety, probiotics for sleep, and our guide to Bifidobacterium deficiency—a condition that may silently undermine both gut and mental health.
The Filler-Free Synbiotic Built for Your Whole System
MicroBiome Restore delivers 26 clinically studied probiotic strains, 7 certified organic whole-food prebiotics, and 80+ trace minerals in a pullulan capsule with zero synthetic fillers. Formulated with the gut-brain axis in mind—because your microbiome affects far more than your digestion.
References
- Appleton, J. (2018). The gut-brain axis: Influence of microbiota on mood and mental health. Integrative Medicine: A Clinician's Journal, 17(4), 28–32. https://pmc.ncbi.nlm.nih.gov/articles/PMC6469458/
- Asad, A., Kirk, M., Zhu, S., Dong, X., & Gao, M. (2025). Effects of prebiotics and probiotics on symptoms of depression and anxiety in clinically diagnosed samples: Systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews, 83(7), e1504–e1520. https://doi.org/10.1093/nutrit/nuae177
- Bravo, J. A., Forsythe, P., Chew, M. V. K., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the National Academy of Sciences, 108(38), 16050–16055. https://doi.org/10.1073/pnas.1102999108
- Boehme, M., Rémond-Derbez, N., Lerond, C., Lavalle, L., Keddani, S., Steinmann, M., Rytz, A., Dalile, B., Verbeke, K., Van Oudenhove, L., Steiner, P., Berger, B., Vicario, M., Bergonzelli, G., Colombo Mottaz, S., & Hudry, J. (2023). Bifidobacterium longum subsp. longum reduces perceived psychological stress in healthy adults: An exploratory clinical trial. Nutrients, 15(14), 3122. https://doi.org/10.3390/nu15143122
- Chong, H. X., Yusoff, N. A., Hor, Y. Y., Lew, L. C., Jaafar, M. H., Choi, S. B., Yusoff, M. S. B., Wahid, N., Abdullah, M. F. I. L., Zakaria, N., Ong, K. L., Park, Y. H., & Liong, M. T. (2019). Lactobacillus plantarum DR7 alleviates stress and anxiety in adults: A randomised, double-blind, placebo-controlled study. Beneficial Microbes, 10(4), 355–373. https://doi.org/10.3920/BM2019.0009
- Moshfeghinia, R., Nemati, H., Ebrahimi, A., Shekouh, D., Karami, S., Eraghi, M. M., Mohagheghzadeh, H., Hunter, J., & Pasalar, M. (2024). Strain-specific effects of probiotics on depression and anxiety: A meta-analysis. Gut Pathogens, 16, 49. https://doi.org/10.1186/s13099-024-00634-8
- Ortega, M. A., Fraile-Martínez, O., García-Montero, C., Alvarez-Mon, M. A., Lahera, G., Monserrat, J., Llavero-Valero, M., Navarro, E. M., Quintela, J. C., García-Honduvilla, N., Bujan, J., Alvarez-Mon, M., & De Leon-Luis, J. A. (2024). Effectiveness of psychobiotics in the treatment of psychiatric and cognitive disorders: A systematic review of randomized clinical trials. Nutrients, 16(9), 1352. https://doi.org/10.3390/nu16091352
- Clapp, M., Aurora, N., Herrera, L., Bhatia, M., Wilen, E., & Wakefield, S. (2017). Gut microbiota's effect on mental health: The gut-brain axis. Clinics and Practice, 7(4), 987. https://pmc.ncbi.nlm.nih.gov/articles/PMC5641835/
- Barrett, E., Ross, R. P., O'Toole, P. W., Fitzgerald, G. F., & Stanton, C. (2012). γ-Aminobutyric acid production by culturable bacteria from the human intestine. Journal of Applied Microbiology, 113(2), 411–417. https://doi.org/10.1111/j.1365-2672.2012.05344.x
- Lew, L. C., Hor, Y. Y., Yusoff, N. A. A., Choi, S. B., Yusoff, M. S. B., Roslan, N. S., Ahmad, A., Mohammad, J. A. M., Abdullah, M. F. I. L., Zakaria, N., Ong, K. L., Park, Y. H., & Liong, M. T. (2019). Probiotic Lactobacillus plantarum P8 alleviated stress and anxiety while enhancing memory and cognition in stressed adults: A randomised, double-blind, placebo-controlled study. Clinical Nutrition, 38(5), 2053–2064. https://doi.org/10.1016/j.clnu.2018.09.010
- Pinto-Sanchez, M. I., Hall, G. B., Ghajar, K., Nardelli, A., Bolino, C., Lau, J. T., Martin, F. P., Cominetti, O., Welsh, C., Rieder, A., Traynor, J., Gregory, C., De Palma, G., Pigrau, M., Ford, A. C., Macri, J., Berger, B., Bergonzelli, G., Surette, M. G., Collins, S. M., Moayyedi, P., & Bercik, P. (2017). Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: A pilot study in patients with irritable bowel syndrome. Gastroenterology, 153(2), 448–459. https://doi.org/10.1053/j.gastro.2017.05.003
- Tian, P., Chen, Y., Zhu, H., Wang, L., Qian, X., Zou, R., Zhao, J., Zhang, H., Qian, L., Wang, Q., Zhao, J., Zhang, H., Chen, W., & Wang, G. (2022). Bifidobacterium breve CCFM1025 attenuates major depression disorder via regulating gut microbiome and tryptophan metabolism: A randomized clinical trial. Brain, Behavior, and Immunity, 100, 233–241. https://doi.org/10.1016/j.bbi.2021.11.023


Share and get 15% off!
Simply share this product on one of the following social networks and you will unlock 15% off!